Sweden
Tuberculosis profile
Population  2012 9.5 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.013 (0.013–0.013) 0.14 (0.13–0.14)
Mortality (HIV+TB only) <0.01 (<0.01–<0.01) 0.01 (0–0.01)
Prevalence  (includes HIV+TB) 0.92 (0.37–1.7) 9.6 (3.9–18)
Incidence  (includes HIV+TB) 0.68 (0.6–0.77) 7.2 (6.3–8.1)
Incidence (HIV+TB only) <0.01 (<0.01–<0.01) 0.04 (0.04–0.05)
Case detection, all forms (%) 87 (77–99)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 101 (18) Relapse 0 (0)
Smear-negative 182 (32) Treatment after failure 0 (0)
Smear-unknown / not done 51 (9) Treatment after default 1 (3)
Extrapulmonary 229 (41) Other 38 (97)
Other 0 (0)      
Total new 563   Total retreatment 39  
           
Other (history unknown) 30        
Total new and relapse 563   Total cases notified 632  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 1.6 1.3 1.1
Age < 15 0 17 7
Laboratories 2012
Is second-line drug susceptibility testing available? Yes, in country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 83   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 91  
Retreatment 78  
TB/HIV 2012 Number (%)
TB patients with known HIV status    
HIV-positive TB patients    
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 2.4 (1.2–4.3) 8.3 (1–27)
MDR-TB cases among notified pulmonary
TB cases
8 (4–14) 3 (0–11)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 453 (100%) 24 (62%) 503
Laboratory-confirmed MDR-TB cases 11 2 14
Patients started on MDR-TB treatment     12
Financing TB control 2013
National TB programme budget (US$ millions)  
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-16 Data: www.who.int/tb/data